DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

References

Confavreux C, O'Connor P, Comi G et al.
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet Neurol 2014;
13: 247-256

Download Bibliographical Data

Search in:
Access: